US Patent Issued to BioCryst Pharmaceuticals on July 14 for "Pyrrolopyrimidine amines as complement inhibitors" (Alabama Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,843, issued on July 14, was assigned to BioCryst Pharmaceuticals Inc. (Durham, N.C.).

"Pyrrolopyrimidine amines as complement inhibitors" was invented by Pravin L. Kotian (Hoover, Ala.), Yarlagadda S. Babu (Birmingham, Ala.), Minwan Wu (Vestavia Hills, Ala.), Zhao Dang (Vestavia Hills, Ala.), Trung Xuan Nguyen (Hoover, Ala.) and Krishnan Raman (Birmingham, Ala.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of formula (I), and pharmaceutically acceptable salts thereof, which are inhibitors of the complement system. Also provided are pharmaceutical compositions comprising such a compound, and methods of using the compounds and...